Comparison of central nervous system adverse effects of amantadine and rimantadine used as sequential prophylaxis of influenza A in elderly nursing home patients.
about
Perspectives on antiviral use during pandemic influenzaCompounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part I: Influenza life-cycle and currently available drugsCost-effective approaches to influenza prevention and treatment.Novel strategies for prevention and treatment of influenza.Recent advances in the diagnosis and treatment of influenza pneumonia.Influenza prophylaxis in the long-term care facility: a case-control study of the risk factors for adverse drug reactions to amantadine.Adverse cutaneous reactions to influenza vaccinations and chemotherapy.Using mutagenesis to explore conserved residues in the RNA-binding groove of influenza A virus nucleoprotein for antiviral drug development.A new role of neuraminidase (NA) in the influenza virus life cycle: implication for developing NA inhibitors with novel mechanism of action.rac-2-{[1-(1-Adamant-yl)eth-yl]imino-meth-yl}-5-meth-oxy-phenol.Pharmacokinetics and safety of coadministered oseltamivir and rimantadine in healthy volunteers: an open-label, multiple-dose, randomized, crossover study.Synthesis of three rimantadine schiff bases and their biological effects on serum albumin.Adverse effects of amantadine and oseltamivir used during respiratory outbreaks in a center for developmentally disabled adults.Anti-influenza therapy: the emerging challenge of resistance
P2860
Q24522384-5099AEF6-6BEB-43A6-82DF-F268D2CC8288Q28085400-03450BC9-7387-4D18-9ADB-BE44917C1760Q30233084-75481CCB-63C6-4B55-A807-2195AFCB104CQ30350342-A8F23E70-7F3E-44FE-A260-F621F4AAADA7Q30415002-29A00822-213C-4D55-ABB3-3A560AD91755Q33739094-7C550633-F6D6-407A-A02A-5A547147AD43Q34419159-278DA421-5BF0-479F-B535-9BCC464BC45BQ38641540-44DDB3E4-3810-48F1-BAE2-FEC7F7F29068Q38802959-BC0A9C30-7E7C-4C18-8316-FAB205ABDE2FQ38814413-A6B93BE4-C8DC-43FA-86E7-39E48683A3C8Q42622839-9D8CD76E-D141-4449-BA03-E51918305156Q43007137-BC076535-FB0C-4805-9B3F-6C58035C35EEQ45164155-0A3ADD7C-8306-413D-9634-326E33521EE5Q58066873-46786099-F183-4108-B14B-79261DF58827
P2860
Comparison of central nervous system adverse effects of amantadine and rimantadine used as sequential prophylaxis of influenza A in elderly nursing home patients.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Comparison of central nervous ...... elderly nursing home patients.
@ast
Comparison of central nervous ...... elderly nursing home patients.
@en
type
label
Comparison of central nervous ...... elderly nursing home patients.
@ast
Comparison of central nervous ...... elderly nursing home patients.
@en
prefLabel
Comparison of central nervous ...... elderly nursing home patients.
@ast
Comparison of central nervous ...... elderly nursing home patients.
@en
P2093
P1476
Comparison of central nervous ...... elderly nursing home patients.
@en
P2093
Bertino JS Jr
Nafziger AN
P304
P356
10.1001/ARCHINTE.160.10.1485
P407
P577
2000-05-01T00:00:00Z